Holen Sie sich die Stockscreener-App
0.4601
11.65%
0.048
Handel nachbörslich:
.49
0.0299
+6.50%
Schlusskurs vom Vortag:
$0.4121
Offen:
$0.4432
24-Stunden-Volumen:
376.18M
Relative Volume:
3.37
Marktkapitalisierung:
$85.99M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-121.02M
KGV:
-0.0409
EPS:
-11.26
Netto-Cashflow:
$-114.09M
1W Leistung:
+92.59%
1M Leistung:
+36.29%
6M Leistung:
-16.35%
1J Leistung:
-95.27%
1-Tages-Spanne:
$0.365
$0.583
1-Wochen-Bereich:
$0.2375
$0.583
52-Wochen-Spanne:
$0.118
$12.48
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Company Profile
Firmenname
Tonix Pharmaceuticals Holding Corp
Sektor
Branche
Telefon
212-980-9155
Adresse
26 MAIN STREET, SUITE 101, CHATHAM, NY
Vergleichen Sie TNXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TNXP
Tonix Pharmaceuticals Holding Corp
|
0.4601 | 85.99M | 0 | -121.02M | -114.09M | -11.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.68 | 113.49B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
686.33 | 75.42B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
648.11 | 39.38B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
279.19 | 36.01B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
124.30 | 29.80B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tonix Pharmaceuticals Holding Corp Stock (TNXP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-04-18 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-04-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2017-08-18 | Hochstufung | ROTH Capital | Neutral → Buy |
| 2016-09-07 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2016-02-17 | Bestätigt | Oppenheimer | Outperform |
| 2015-11-04 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2015-06-12 | Eingeleitet | Oppenheimer | Outperform |
| 2015-02-17 | Bestätigt | ROTH Capital | Buy |
| 2014-09-29 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tonix Pharmaceuticals Holding Corp Aktie (TNXP) Neueste Nachrichten
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 21.8%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 11.5%What's Next? - MarketBeat
StockNews.com Initiates Coverage on Tonix Pharmaceuticals (NASDAQ:TNXP) - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 22.4% HigherWhat's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 13.2%Should You Buy? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 7.6%Should You Buy? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 13.2%Here's Why - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 7.6%Should You Buy? - MarketBeat
Tonix Pharmaceuticals Holding (LTS:0A4T) Liabilities-to-Ass - GuruFocus.com
Tonix Pharmaceuticals Holding (LTS:0A4T) Price-to-Operating-Cash-Flow : (As of Jan. 17, 2025) - GuruFocus.com
FDA accepts Tonix’s NDA for non-opioid fibromyalgia drug TNX-102 SL - MSN
Tonix Pharmaceuticals Holding (LTS:0A4T) Net Income : $-135.25 Mil (TTM As of Sep. 2024) - GuruFocus.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Hold Rating from Analysts at StockNews.com - Defense World
Tonix Pharmaceuticals Holding (LTS:0A4T) Altman Z-Score : -14.06 (As of Jan. 16, 2025) - GuruFocus.com
Why Taiwan Semiconductor Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket - Benzinga
Tonix Pharmaceuticals Holding (LTS:0A4T) 9-Day RSI : N/A (As of Jan. 15, 2025) - GuruFocus.com
Rivoluzionare la salute con i virus? Una nuova era per le scoperte biotecnologiche - Be3
(TNXP)Analyzing Tonix Pharmaceuticals's Short Interest - Benzinga
Revolutionizing Health with Viruses? A New Age for Biotech Breakthroughs - Be3
Tonix Pharmaceuticals Further Strengthens Commercial - GlobeNewswire
Tonix Pharma Announces Key Appointment and Study Timelines - TipRanks
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access - The Manila Times
Tonix Pharmaceuticals Strengthens Commercial Team Ahead of Critical FDA Decision on Fibromyalgia Drug - StockTitan
Tonix Is A Buy For Potentially Great Return On PTSD Breakthrough, Part 2 (NASDAQ:TNXP) - Seeking Alpha
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 7.2%Time to Sell? - MarketBeat
Tonix Pharmaceuticals Holding Corp at SNN Planet MicroCap Showcase Transcript - GuruFocus.com
Tonix Pharmaceuticals to Present at Two Upcoming January Investor Conferences - The Manila Times
Tonix Pharmaceuticals CEO to Present Pipeline Updates at Major Neuroscience and Biotech Forums - StockTitan
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 2.5%Time to Buy? - MarketBeat
SABBY MANAGEMENT, LLC Acquires 1,306,313 Shares in Tonix Pharmaceuticals Holding Corp - GuruFocus.com
What’s Next for TNXP? The Future of Biotech and Stock Surges - Be3
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.5%What's Next? - MarketBeat
Tonix Receives PDUFA Goal Date for Sleep-Enhancing Fibromyalgia Drug Candidate - Sleep Review
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.5%What's Next? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 8.4%Time to Sell? - MarketBeat
Top 5 Biotech Stocks Dominating Retail Investor Conversations In 2024 - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Now Covered by StockNews.com - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 7.8%Should You Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 5.3%What's Next? - MarketBeat
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Short Interest Up 151.6% in December - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 8.7%Time to Sell? - MarketBeat
This Micro Cap Is Getting Bid Up Prior To Opening Bell - MSN
Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 2.6%Should You Sell? - MarketBeat
Certain Options of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Certain Warrants of Tonix Pharmaceuticals Holding Corp. are subject to a Lock-Up Agreement Ending on 26-DEC-2024. - Marketscreener.com
Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 4.4%Time to Sell? - MarketBeat
Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 3.2%What's Next? - MarketBeat
FDA sets review goal date for Tonix fibromyalgia drug By Investing.com - Investing.com South Africa
Finanzdaten der Tonix Pharmaceuticals Holding Corp-Aktie (TNXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):